These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8572815)

  • 21. [Exogenous adenosine in cardioplegia].
    Haverich A; Karck M
    Z Kardiol; 1996; 85 Suppl 6():201-4. PubMed ID: 9064966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
    Zhu B; Min S; Long C; Ye T
    Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current status of research on the myocardial protection during open heart surgery].
    Long C; Liu K
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2305-6. PubMed ID: 18036288
    [No Abstract]   [Full Text] [Related]  

  • 25. Myocardial protection in pediatric cardiac surgery.
    Turkoz R
    Artif Organs; 2013 Jan; 37(1):16-20. PubMed ID: 23305570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intraoperative myocardial protection with magnesium-asparatate-procaine (Kirsch's solution)-cardiac arrest and cardioplegic coronary perfusion with cold solution containing HES (author's transl)].
    Kato I; Kaihatsu N; Okada K; Fukuda T; Sugimoto T; Koide Y; Tajima K; Nakai Y; Nakano O; Kataoka Y; Fukata Y; Kurokami K
    Kyobu Geka; 1978; 31(7):494-9. PubMed ID: 80467
    [No Abstract]   [Full Text] [Related]  

  • 27. [The relationship between myocardial temperature and its long-term effects on myocardial protection].
    Araki K; Koga Y; Ishii K; Sugimoto H; Nakajima S; Onitsuka T; Sibata K
    Rinsho Kyobu Geka; 1987; 7(2):150-3. PubMed ID: 9301769
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myocardial protection: which method of cardioplegia is better?].
    Nasvytis L; Sirvinskas E
    Medicina (Kaunas); 2002; 38(8):797-800. PubMed ID: 12474750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective effect of ischemic preconditioning with University of Wisconsin solution on rat heart preservation: what is the optimal duration of preconditioning ischemia?
    Saitoh Y; Gu K; Kin S; Yamauchi M; Sasaki T; Nosaka S; Hashimoto M; Nakayama K; Tamura K
    Transplant Proc; 1996 Feb; 28(1):286-8. PubMed ID: 8644227
    [No Abstract]   [Full Text] [Related]  

  • 31. New strategies in myocardial preservation.
    Menasché P
    Curr Opin Cardiol; 1997 Nov; 12(6):504-14. PubMed ID: 9429820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New methods of myocardial protection for cardiac surgery.
    Kay H; Laks H; Hammond GL; Geha AS
    Conn Med; 1980 Jun; 44(6):357-61. PubMed ID: 6995003
    [No Abstract]   [Full Text] [Related]  

  • 33. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection.
    Kolocassides KG; Galiñanes M; Hearse DJ
    J Mol Cell Cardiol; 1996 Mar; 28(3):623-34. PubMed ID: 9011645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative assessment of the myocardium protection by methods of blood and crystalloid cardioplegia in patients with high risk of coronary bypass grafting operation].
    Khudonogova SV; Kurapeev IS; Naĭmushin AV; Gordeev ML
    Vestn Khir Im I I Grek; 2002; 161(5):19-22. PubMed ID: 12661241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The crystalloid cardioplegia: advantages with a word of caution.
    Angeli E
    Ann Fr Anesth Reanim; 2011 May; 30 Suppl 1():S17-9. PubMed ID: 21703479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial energy metabolism and protection of heart muscle at low temperatures.
    Watanabe T; Murashige H; Naito T; Sassa S; Takahashi S; Asazuma S; Hashimoto I
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():485-9. PubMed ID: 1032002
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of simultaneous antegrade/retrograde cardioplegia on cellular volumes and energy metabolism.
    Li G; Tian W; Wang J; Xiang B; Wang L; Deng J; Salerno TA; Deslauriers R; Tian G
    J Card Surg; 2008; 23(5):437-43. PubMed ID: 18928482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New strategies for intraoperative myocardial protection.
    Flameng W
    Curr Opin Cardiol; 1995 Nov; 10(6):577-83. PubMed ID: 8573977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organ arrest, protection and preservation: natural hibernation to cardiac surgery.
    Dobson GP
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Nov; 139(3):469-85. PubMed ID: 15544969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
    Hearse DJ; Ferrari R; Sutherland FJ
    J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.